Explore the full record of transactions filed by Hayden Michael R, Director. Insider active across 4 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 10 disclosures have been published. Total volume traded: €4.3m. The latest transaction was filed on 15 October 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Michael R. Hayden is a Board Member at Xenon Pharmaceuticals Inc. and AbCellera Biologics Inc. He contributes to the governance of these companies, providing his expertise to guide strategic decisions and ensure compliance with industry standards.